Briefly, apoA-IMilano is an apoA-I mutant resulting from an arginine 173 to cysteine mutation [306,307], leading to a higher life expectancy in heterozygotes and a lower atherosclerosis rate [304]. The gene discussed is APOA1; the disease is atherosclerosis.